(19)

(11)

EP 4 308 685 A1

(12)

(43) Date of publication: 24.01.2024 Bulletin 2024/04 (21) Application number: 22721542.3 (22) Date of filing: 11.04.2022

(51) International Patent Classification (IPC):  C12M 3/06(2006.01) F16K 11/20(2006.01) C12M 1/00(2006.01) F16K 99/00(2006.01) (52) Cooperative Patent Classification (CPC): C12M 23/40; C12M 23/16; F16K 99/0015; F16K 99/0028; F16K 2099/0084 (86) International application number: PCT/US2022/024227 (87) International publication number: WO 2022/221176 (20.10.2022 Gazette 2022/42)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 12.04.2021 US 202163173719 P (71) Applicant: Octane Biotech Inc. Kingston, ON K7K 6Z1 (CA)	(72) Inventors: SZARAZ, Peter Kingston, Ontario K7K 6Z1 (CA) TRAINOR, Nuala Kingston, Ontario K7K 6Z1 (CA) (74) Representative: Greiner, Elisabeth  df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstraße 16 80333 München 80333 München (DE)